TianjinPharmaceutical Holdings Co., Ltd. (Tianjin Pharma) is a large pharmaceuticalgroup with a relatively complete pharmaceutical industry chain in China, andhas been selected as one of the top 100 pharmaceutical enterprises in China forconsecutive years.

TianjinPharma holds 2 listed companies on the main board (Tianjin Pharmaceutical DaRen Tang Group Corporation Limited (A stock ticker symbol: 600329, S stockticker symbol: T14) and Tianjin Tianyao Pharmaceuticals Co., Ltd. (A stock ticker symbol:600488)), and 2 listed companies on the NEEQ (MEDA Co., Ltd. (NEEQ tickersymbol: 430220) and NewScen Coast Bio Pharmaceutical Co., Ltd. (NEEQ tickersymbol: 872334)).

TianjinPharma owns more than ten key industrial production enterprises, such as Da RenTang, No.6 Chinese Medicine Plant, Long Shun Rong, Le Ren Tang, Jingwanhong, Tianjin Tianyao Pharmaceuticals Co., Ltd., Jin Yao Hepin and Jinyao Yumeijing, and many pharmaceuticalcommercial enterprises, such as Zhongxin Pharmaceutical Plant, Jinyao Pacific PharmaceuticalCo., Ltd. and Jinyao Jinyitang Co., Ltd..

TianjinPharma advocates the core values of “love, quality and strength”, and alwaystakes it as its responsibility to improve people’s health and well-being, and protectpeople’s lives. It will make contributions to the construction of healthy Chinaand the safeguarding of everyone’s better life, and strive to develop into amarket-driven and technology-empowered leader in health industry!